Combined Inhibition of Topoisomerases I and II - Is This a Worthwhile/Feasible Strategy?

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1997.568
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC